Analysis of class II genes of human leukocyte antigen in patients with Moyamoya disease

Clinical Neurology and Neurosurgery

Volumn 99, Issue SUPPL. 2, 1997, Pages

  Inoue, Takuya K ^a   Ikezaki, Kiyonobu ^a   Sasazuki, Takehiko ^a   Matsushima, Toshio ^a   Fukui, Masashi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cerebrovascular disease; Class II genes; DNA; Genetic; Human leukocyte antigen typing; Moyamoya disease

Indexed keywords

LEUKOCYTE ANTIGEN;

ALLELE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DETERMINATION; FEMALE; GENOTYPE; HEREDITY; HLA TYPING; HUMAN; INTERNAL CAROTID ARTERY; JAPAN; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION;

EID: 0030670561     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0303-8467(97)00051-6     Document Type: Conference Paper

References (38)

1. Kudo T. Spontaneous occlusion of the circle of Wllis: A disease apparently confined to Japanese. Neurology. 20:1968;485-496.
2. Nishimoto A., Takeuchi S. Abnormal cerebrovascular network related to the internal carotid arteries. J Neurosurg. 29:1968;255-260.
3. Suzuki J., Takaku A. Cerebrovascular Moyamoya disease: Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 20:1969;288-299.
4. Wakai K, Tamakoshi A, Ohno Y, Kawamura T, Ikezaki K, Fukui M. Epidemiology of Moyamoya disease in Japan: Findings from a nationwide survey, in: 1995 Annual Report of the Research Committee on Spontaneous Occlusion of the Circle of Willis. 1996:33-38 (in Japanese).
5. Suzuki J., Kodama N. Moyamoya disease: A review. Stroke. 14:1983;104-109.
6. Kitahara T., Okumura K., Senba A., Yamaura A., Makino H. Genetic and immunologic analysis on Moyamoya. J Neurol Neurosurg Psychiatry. 45:1982;1048-1052.
7. Ikeda E., Hosoda Y. Distribution of the thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of willis: Cerebrovascular Moyamoya disease. Clin Neuropathol. 12:1993;44-48.
8. Ikeda E., Maruyama I., Hosoda Y. Expression of thrombomodulin in patients with spontaneous occlusion of the circle of Willis. Stroke. 24:1993;657-660.
9. Masuda J., Ogata J., Yutani C. Smooth muscle cell proliferation and localization of macrophages and T-cells in the occlusive intracranial major arteries in Moyamoya disease. Stroke. 24:1993;1960-1967.
10. 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with Moyamoya disease. J Cell Physiol. 154:1993;281-288.
11. Suzuki H., Hoshimaru M., Takahashi J.A., Kikuchi H.et al. Immunohistochemical reaction for growth facter receptor in arteries of patients with Moyamoya disease. Neurosurg. 35:1994;20-25.
12. Goto Y., Yonekawa Y. Worldwide distribution of Moyamoya disease. Neurol Med Chir (Tokyo). 32:1992;883-886.
13. Ikezaki K, Han D-H, Kawano T, Inamura T, Fukui M. Epidemiological survey of Moyamoya disease in Korea. Clin Neurol Neurosurg 1997 (in press).
14. Kanai N, Fukuyama Y. A genetic study of spontaneous occlusion of the circle of willis (Moyamoya disease). Tokyo Joshi Ika Daigaku Zassi, 1992;62:1227-1258 (abstract in English).
15. Woody R.C., Perrot L.J., Beck S.A. Neurofibromatosis cerebral vasculopathy in an infant: Clinical, neuroradiologic and neuropathologic studies. Pediatr Pathol. 12:1992;613-619.
16. Pavlakis S.G., Verlander P.C., Gould R.J., Strimling B.C. Fanconi anemia and Moyamoya: Evidence for an association. Neurology. 45:1995;998-1000.
17. Gadoth N. On the probrem of essential and secondary Moyamoya and vascular dysplasia in Down syndrome. Brain Dev. 15:1993;317-318.
18. Aoyagi M., Ogami K., Matsushima Y., Shikata M., Yamamoto M., Yamamoto K. Human leukocyte antigen in patients with Moyamoya disease. Stroke. 26:1995;415-417.
19. Kitamura K. Revision of the diagnostic guide of the Spontaneous occlusion of the circle of Willis. In: 1987 Annual Report of the Research Committee on Spontaneous Occlusion of the Circle of Willis. 1988:119-122 (in Japanese).
20. Bodmer J.G., Marsh S.G.E., Albert E.D.et al. Nomenclature for factors of the HLA system. Tissue Antigens. 46:1995;1-18.
21. Kimura A, Sasazuki T. Eleventh international histocompatibility workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991: Proceeding of the Eleventh International Workshop and Conference. Vol. 1. Oxford: Oxford University Press, 1992:397-419.
22. Kimura A., Dong R.P., Harada H., Sasazuki T. DNA typing of HLA classII genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens. 40:1992;5-12.
23. Date Y., Kimura A., Kato H., Sasazuki T. DNA typing of the HLA-A gene: Population study and identification of four new alleles in Japanese. Tissue Antigens. 47:1996;93-101.
24. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 19:1995;251-253.
25. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 103:1976;226-235.
26. Haldane S. The estimation and signicance of the logarithm of a ratio of frequencies. Ann Hum Genet. 20:1956;309-311.
27. Allen M. Genetic typing of HLA polymorphism: Application to studies of disease association and forensic medicine. Acta Universitatis Uppsaliensis; Comprehensive summaries of Uppsala dissertations from the faculty of medicine. HLA Disease. 547:1995;15-17.
28. Todd J.A., Acha-Orbea H., Bell J.I.et al. A molecular basis for MHC classII-asociated autoimmunity. Science. 240:1988;1003-1009.
29. Sasazuki T., Nishimura Y., Muto M., Onta N. HLA-linked genes controlling the immune response and disease susceptibility. Immunol Rev. 70:1983;51-75.
30. Hirayama K., Matsushita S., Kikuchi I., Iuchi M., Ohta N., Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature. 327:1987;426-430.
31. Nishimura Y., Sasazuki T. Suppressor T-cells control the HLA-linked low responsiveness to streptococcal antigen in human. Nature. 327:1987;426-430.
32. Burt R.D., Vaughan T.L., Nisperos B., Swanson M., Berwick M. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US caucasians. Int J Cancer. 56:1994;465-467.
33. Ikegami H., Makino S., Yamato E.et al. Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping. J Clin Invest. 96:1995;1936-1942.
34. Satsangi J., Welsh K.I., Bunce M. Contribution of genes of the major histocompatibility complex to susceptivility and disease phenotype in inflammatory bowel disease. Lancet. 347:1996;1212-1217.
35. Dong R.P., Kimura A., Numano F., Nishimura Y., Sasazuki T. HLA-linked susceptibility and resistance to Takayasu arteritis. Heart Vessels. 7:1992;73-80.
36. Hosoda Y. Pathology of so-called apontaneous occlusion of the circle of Willis. Pathol Ann. 19:1984;221-244.
37. Yamashita M., Oka K., Tanaka K. Histopathology of the brain vascular network in Moyamoya disease. Stroke. 22:1991;1358-1362.
38. Panegyres P.K., Morris J.G., O'Neill P.J., Balleine R. Moyamoya-like disease with inflammation. Eur Neurol. 33:1993;260-263.